Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Extractable nuclear antigen contains ribo-nuclease-sensitive (ribonucleoprotein) and ribonuclease-resistant (Sm) components. To determine the diagnostic usefulness of antibodies to these antigens, a multicenter study was undertaken in which serums were analyzed for these antibodies and the findings compared with clinical and other laboratory characteristics of the patients. Of 100 patients with hemagglutinating antibodies to ribonuclease-sensitive extractable nuclear antigen, and only the same antibodies by immunodiffusion, 74 per cent had typical features of mixed connective-tissue disease; 12 features of systemic lupus erythematosus, eight those of scleroderma and six an undifferentiated mild connective-tissue disease. Of 27 patients with hemagglutinating antibodies to ribonuclease-resistant extractable nuclear antigen (and Sm antibodies by immunodiffusion), 85 per cent had typical systemic lupus. Thus, antibodies to nuclear ribonucleoprotein and Sm are of diagnostic use; if the serum contains only ribonucleoprotein antibody in high titer, it is likely that the patient has mixed connective-tissue disease.

[1]  E. Tan,et al.  Profiles of antinuclear antibodies in systemic rheumatic diseases. , 1975, Annals of internal medicine.

[2]  M. D. Parker.  Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. , 1973, The Journal of laboratory and clinical medicine.

[3]  G. Sharp,et al.  Mixed connective tissue disease in a child. , 1973, The Journal of pediatrics.

[4]  E. Tan,et al.  Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence , 1972 .

[5]  M. Mattioli,et al.  Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. , 1972, The New England journal of medicine.

[6]  H. Holman,et al.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). , 1972, The American journal of medicine.

[7]  N. Cooper,et al.  SERUM AND CEREBRAL SPINAL FLUID COMPLEMENT AND SERUM AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1971, Medicine.

[8]  H. Holman,et al.  Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. , 1971, The Journal of clinical investigation.

[9]  C. Blondin,et al.  Role of IgG and IgM antinuclear antibodies in formation of lupus erythematosus cells and extracellular material. , 1970, Arthritis and rheumatism.

[10]  I. Olitzky.  Standardized, automated procedure for measurement of serum hemolytic complement activity. , 1968, Applied microbiology.

[11]  E. Tan.  Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. , 1967, The Journal of laboratory and clinical medicine.

[12]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[13]  C. Mcewen,et al.  Agglutination and inhibition by serum globulin in the sensitized sheep cell agglutination reaction in rheumatoid arthritis. , 1956, The American journal of medicine.

[14]  J. Vaughan,et al.  Current status of the rheumatoid factor. , 1962, Annals of internal medicine.